Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic - Paterson, Ross W.; Slattery, Catherine F.; Poole, Teresa; Nicholas, Jennifer M.; Magdalinou, Nadia K.; Toombs, Jamie; Chapman, Miles D.; Lunn, Michael P.; Heslegrave, Amanda J.; Foiani, Martha S; Weston, Philip S. J.; Keshavan, Ashvini; et al. (Alzheimer's research & therapy, 2018)
Keywords: Aged; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - diagnosis; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-protein; Biological markers; Biomarkers; Biomarkers - cerebrospinal fluid; Biomedical and Life Sciences; Biomedicine; Care and treatment; Cerebrospinal fluid; Cohort Studies; Diagnosis; Diagnosis, Differential; Differential diagnosis; Female; Genetic aspects; Geriatric Psychiatry; Geriatrics/Gerontology; Health aspects; Humans; Identification and classification; Male; Middle Aged; Neurologi; Neurology; Neurosciences; Neurovetenskaper; Phosphorylation; ROC Curve; Sensitivity and Specificity; Tau proteins; tau Proteins - cerebrospinal fluid; Biomarkers; Differential diagnosis; Cerebrospinal fluid; Alzheimer’s disease